Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Eyecare in Aged Care: A systematic review of the prevalence of eye disease, visual impairment, and eye medication usage in residential aged care
Author Affiliations & Notes
  • Isabelle Jalbert
    School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia
  • Sophia Chen
    School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia
  • Monica Tran
    School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia
  • Kirsten Challinor
    Australian Catholic University School of Behavioural and Health Sciences, Sydney, New South Wales, Australia
    School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia
  • Footnotes
    Commercial Relationships   Isabelle Jalbert None; Sophia Chen None; Monica Tran None; Kirsten Challinor None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6384. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Isabelle Jalbert, Sophia Chen, Monica Tran, Kirsten Challinor; Eyecare in Aged Care: A systematic review of the prevalence of eye disease, visual impairment, and eye medication usage in residential aged care. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6384.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A systematic review was conducted to synthesize the prevalence of eye conditions and visual impairment within the residential aged care population. A secondary aim was to summarise the frequency of use of eye mediations that are administered to residents.

Methods : Four databases, the grey literature and the reference lists of relevant studies were searched to identify peer-reviewed studies published in English since January 2003. Prospective and retrospective primary studies were included if they considered all aged-care residents as the denominator and estimated the prevalence of one or more eye conditions, visual impairment, or blindness or the frequency of use of ophthalmic medicines (or a combination of 2 or more of these outcomes). Title and abstract screening of 1,112 and full-text review of 33 studies was conducted using Covidence. The quality of the studies was evaluated by the AXIS tool,. Data regarding study design and key findings were extracted to an excel spreadsheet. All steps were performed by two independent reviewers and disagreements were resolved by discussion with another author.

Results : Eighteen studies were included from 10 countries involving 26,763 residents (range 131 to 8,685). The most prevalent eye disease reported was cataracts, followed by age-related macular degeneration, glaucoma, diabetic retinopathy, dry eye, and blepharitis. The prevalence of vision impairment and blindness in residents ranged from 18.7 to 57.3% and 1% to 36.1%, respectively. Few studies (n=3) investigated ocular medicines usage. Lubricants were used most frequently (9.4% to 25.6%) followed by topical anti-glaucoma eyedrops (5.4% to 11%). A single study reported that 4.8% of residents were prescribed topical anti-infective eyedrops. Risk of bias was judged to be moderate to high for the majority (13 of 18) of studies. Studies estimated prevalence from eye examinations, questionnaires or surveys, interviews, or by extracting information from medical records or health insurance data.

Conclusions : Eye diseases and vision impairment are highly prevalent in residential aged care, suggesting the need for dedicated capabilities in these settings. These findings may be explained in part by pre-existing conditions prior to entry, barriers to access to eyecare services, and prioritisation of co-morbidities.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×